Inhibition of METTL14 not only promotes the proliferation and accumulation of cytotoxic tumor-infiltrating CD8 + T cells, but also induces the secretion of IFNC, CXCL9, and CXCL 10, which enhances the efficacy of immunotherapy and inhibits cancer proliferation [96]. The gene discussed is CD8A; the disease is neoplasm.